TEOSYAL PureSense Redensity 2 is TEOXANE’s dedicated tear-trough filler: a cross-linked hyaluronic acid with a dermo-restructuring complex (8 amino acids, 3 antioxidants, vitamin B6, zinc and copper) and 0.3% lidocaine, supplied as two 1 mL prefilled syringes. A CE-marked Class III Swiss device, it is designed to correct the tear-trough and superficial under-eye hollows in the delicate infraorbital area. Professional use only.
What is Teosyal Redensity 2?
TEOSYAL PureSense Redensity 2 is TEOXANE’s dedicated tear-trough filler: a cross-linked hyaluronic acid formulated with a dermo-restructuring complex — eight amino acids, three antioxidants, vitamin B6 and the minerals zinc and copper — and 0.3% lidocaine for comfort. Its smooth, low-volume gel is purpose-built for the delicate infraorbital (under-eye) area. Supplied as two 1 mL prefilled syringes. It is a CE-marked Class III device manufactured in Geneva.
How does Redensity 2 differ from Redensity 1?
The two TEOSYAL Redensity products are separate SKUs for different jobs. Redensity 1 is a non-cross-linked skin-quality booster (hydration and fine-line prevention), supplied as a single 3 mL syringe. Redensity 2 is a cross-linked filler designed to correct the tear-trough and restore light volume under the eye, supplied as two 1 mL syringes. Both carry the TEOSYAL nutrient complex and 0.3% lidocaine; the treating clinician selects by indication.
| Teosyal Redensity 1 | Non-cross-linked HA 15 mg/mL booster · skin quality / fine lines · 1 × 3 mL |
|---|---|
| Teosyal Redensity 2 | Cross-linked HA filler · tear-trough / under-eye · 2 × 1 mL |
What do clinics use Redensity 2 for?
Redensity 2 is marketed for correction of the tear-trough and superficial under-eye hollows and for soft volume restoration in the delicate infraorbital area. Its cohesive, low-swelling gel is designed to sit smoothly in thin periocular skin. Suitability, depth and technique are decided by the treating clinician; needles are supplied and fine cannulas are commonly used in this area.
Commonly selected for
- Tear-trough and infraorbital hollows
- Soft, low-volume under-eye correction
- Patients wanting a lidocaine-containing filler
- Practices already using the TEOSYAL range
How is Redensity 2 supplied and stored?
Two 1 mL prefilled syringes per box with sterile needles and traceability labels. Store between 2 °C and 25 °C away from direct sunlight, per the manufacturer’s IFU.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | TEOSYAL® PureSense Redensity 2 (TEOXANE) |
|---|---|
| Manufacturer | TEOXANE S.A. (Geneva, Switzerland) |
| Origin | Switzerland |
| Active | Cross-linked hyaluronic acid + lidocaine hydrochloride 0.3% |
| Format | 1 mL prefilled syringe |
| Areas | Infraorbital (tear-trough) area and superficial under-eye hollows |
| Administration | Injectable — by a qualified medical professional only |
| Storage & handling | Store between 2 °C and 25 °C, away from direct sunlight (manufacturer IFU) |
| Complex | Dermo-restructuring complex: 8 amino acids · 3 antioxidants · vitamin B6 · zinc · copper |
| Presentation | 2 syringes per box with needles |
| Regulatory | CE-marked Class III medical device (EU MDR) |
Frequently asked questions
What is Teosyal Redensity 2 used for?
Correction of the tear-trough and superficial under-eye hollows, and soft volume restoration in the delicate infraorbital area.
How is Redensity 2 different from Redensity 1?
Redensity 2 is a cross-linked filler for the tear-trough (2 × 1 mL); Redensity 1 is a non-cross-linked skin-quality booster for hydration and fine lines (1 × 3 mL). They are separate products.
Does Redensity 2 contain lidocaine?
Yes — the PureSense version contains 0.3% lidocaine hydrochloride for a more comfortable treatment.
How is it supplied and stored?
Two 1 mL prefilled syringes per box with needles. Store between 2 °C and 25 °C away from direct sunlight, per the manufacturer’s IFU.